MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 225 filers reported holding MYRIAD GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $29,000 | -19.4% | 2,523 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $36,000 | -47.8% | 2,523 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $69,000 | -4.2% | 2,523 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $72,000 | +2.9% | 2,523 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $70,000 | -16.7% | 2,523 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $84,000 | +15.1% | 2,523 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $73,000 | -62.4% | 2,523 | -40.3% | 0.01% | -54.5% |
| Q3 2018 | $194,000 | +5.4% | 4,224 | -14.3% | 0.01% | 0.0% |
| Q2 2018 | $184,000 | +27.8% | 4,931 | +1.2% | 0.01% | +22.2% |
| Q1 2018 | $144,000 | -12.7% | 4,874 | +1.7% | 0.01% | -10.0% |
| Q4 2017 | $165,000 | +79.3% | 4,791 | +88.5% | 0.01% | +100.0% |
| Q3 2017 | $92,000 | +24.3% | 2,541 | -11.6% | 0.01% | 0.0% |
| Q2 2017 | $74,000 | +34.5% | 2,875 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $55,000 | – | 2,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |